Aurinia Pharmaceuticals (AUPH) Q1 2025 Earnings
Aurinia Pharmaceuticals reported Q1 2025 revenue of $62.5M (+24.2% YoY), missed analyst consensus of $64.6M by $2.2M. Diluted EPS came in at $0.16, beat the $0.08 consensus by $0.08.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Aurinia Pharmaceuticals's Q1 2025 earnings report.
Aurinia Pharmaceuticals (AUPH) reported Q1 2025 earnings on May 12, 2025 before market open.
Aurinia Pharmaceuticals reported revenue of $62.5M and diluted EPS of $0.16 for Q1 2025.
Revenue missed the consensus estimate of $64.6M by $2.2M. EPS beat the consensus estimate of $0.08 by $0.08.
Compared to the same quarter a year prior, revenue grew 24.2% from $50.3M a year earlier.
You can read the 10-Q periodic report (0001600620-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.